Document is current
Any future updates will be listed below
-
Authors
Xue, Jun-shuai
Maimaitiming, Nuersimanguli
Zhang, Bo-lun
Xu, Bo-wen
Yin, Xin
Huang, Zhen
Che, Xu
Zhao, Hong
Cai, Jian-qiang
-
Funding
Funding for this research was provided by:
Shenzhen High-level Hospital Construction Fund and Supported by Shenzhen Key Medical Discipline Construction Fund (SZSM202011010)
National Natural Science Foundation of China (81972311 & 82141127)
Sanming Project of Medicine in Shenzhen (SZSM202011010)
the Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019PT310026)
National Key Research and Development Program of China (2023YFC3403800 & 2023YFC3403804)
CAMS Innovation Fund for Medical Sciences (2021-I2M-1-066)
CAMS Initiative for Innovative Medicine (2021-I2M-1-015)
CAMS Innovation Fund for Medical Sciences (2021-I2M-C&T-B-057)
- License Information
-
More Information
Article History
Received: 6 April 2024
Accepted: 10 April 2025
First Online: 17 April 2025
Declarations
:
: The study protocol, including treatment protocol and data collection, was in accordance with the Declaration of the Helsinki Association of World Medical Ethics Guidelines. Approved by the Research Ethics Committee of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College and individual written informed consent for this retrospective analysis was waived.
: The authors declare no competing interests.
: There are no conflicts of interest to declare.
